The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PERSPECTIVE ROUNDTABLE

PreviousPrevious
Volume 360:e10 February 19, 2009 Number 8
NextNext

CABG vs. Stenting — Clinical Implications of the SYNTAX Trial
Thomas H. Lee, M.D., L. David Hillis, M.D., and Elizabeth G. Nabel, M.D.

 

This Article
- PDF
-PDA Full Text

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
In the international SYNTAX trial, 1800 patients with three-vessel or left-main coronary disease were randomly assigned to either revascularization with coronary-artery bypass grafting (CABG) or percutaneous coronary intervention involving drug-eluting stents. The need for repeat revascularization was significantly lower with CABG, but the risk of stroke was significantly higher — a tradeoff that must be considered in making clinical decisions regarding patients with advanced coronary disease. In a roundtable discussion moderated by Dr. Thomas Lee, cardiologists David Hillis and Elizabeth Nabel debate the implications of these findings for clinical practice.

View the video of this roundtable discussion, participate in the poll, and contribute your comments.


Related Letters:

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting
Bhindi R., Figtree G. A., Edwards J. L., Brereton R. J.L., Misfeld M., Ross D. E., Shil A. B., Aung T., Strohm M. P., Bonvini R. F., Rapp F., Roffi M., Serruys P. W., Mohr F. W., the SYNTAX Investigators
Extract | Full Text | PDF  
N Engl J Med 2009; 360:2672-2675, Jun 18, 2009. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.